Anupam Rasayan India Ltd has acquired Bliss GVS Pharma Ltd for an undisclosed amount. This corporate acquisition sees Anupam Rasayan taking ownership of a fast-growing pharmaceutical company known for its high-quality formulations and global market presence.
Bliss GVS Pharma Ltd has established itself as a leader in developing, manufacturing, and marketing pharmaceutical formulations at affordable prices. The company is particularly recognized for its expertise in Suppositories and Pessaries dosage forms, holding one of the largest product portfolios in this segment globally. With thirty years of experience, Bliss GVS operates EU-GMP, WHO GMP, OHSAS-18001, and ISO-14001 certified manufacturing plants, notably being the only EU-GMP certified suppositories manufacturer in India. Furthermore, Bliss GVS holds segment leadership in Anti-malarial products across numerous African markets, offering an extensive range of Artemisinin-based combination formulations in various dosage forms.
Over the past decade, Bliss GVS has expanded its know-how into other dosage forms and therapeutic segments, extending its product offerings across more than sixty countries. This growth has been supported by significant investments in R&D, manufacturing, and marketing capabilities. The acquisition by Anupam Rasayan is strategically poised to leverage Bliss GVS’s established pharmaceutical platform, specialized manufacturing capabilities, and extensive global distribution network.
This move provides Anupam Rasayan with immediate access to a robust pharmaceutical business, enhancing its market footprint and diversifying its portfolio. The combined entity is expected to capitalize on Bliss GVS’s proven track record and innovative product development to drive continued growth and deliver high-quality pharmaceutical solutions to a broader global market.